Merry L Tetef

Title(s)HS Clinical Professor, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. ER-Targeted PET for Initial Staging and Suspected Recurrence in ER-Positive Breast Cancer. JAMA Netw Open. 2024 Jul 01; 7(7):e2423435. Ulaner GA, Silverstein M, Nangia C, Tetef M, Vandermolen L, Coleman C, Khan S, MacDonald H, Patel T, Techasith T, Mauguen A. PMID: 39058489; PMCID: PMC11282447.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    2. Tolerability of Breast Radiation Therapy in the Setting of Mondor Disease. Adv Radiat Oncol. 2023 Mar-Apr; 8(2):101120. Lin K, MacDonald HR, Tetef ML, Coleman CL. PMID: 36466190; PMCID: PMC9713261.
      View in: PubMed   Mentions:
    3. Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus. Ther Adv Med Oncol. 2020; 12:1758835920967259. Peddi PF, Tetef M, Coluzzi P, Arzoo KK, Hu EH, Berkowitz MJ, Chan D, Moore D, Adams B, Wang X, Hurvitz SA. PMID: 33299473; PMCID: PMC7711222.
      View in: PubMed   Mentions: 1  
    4. Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer. J Clin Oncol. 2009 May 01; 27(13):2163-9. Chew HK, Doroshow JH, Frankel P, Margolin KA, Somlo G, Lenz HJ, Gordon M, Zhang W, Yang D, Russell C, Spicer D, Synold T, Bayer R, Hantel A, Stiff PJ, Tetef ML, Gandara DR, Albain KS. PMID: 19307510; PMCID: PMC2674003.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    5. Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium Trial. Int J Gynecol Cancer. 2007 Mar-Apr; 17(2):373-8. Morgan RJ, Synold TW, Gandara D, Muggia F, Scudder S, Reed E, Margolin K, Raschko J, Leong L, Shibata S, Tetef M, Vasilev S, McGonigle K, Longmate J, Yen Y, Chow W, Somlo G, Carroll M, Doroshow JH. PMID: 17362315.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    6. Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity. Clin Cancer Res. 2007 Feb 15; 13(4):1232-7. Morgan RJ, Synold TW, Xi B, Lim D, Shibata S, Margolin K, Schwarz RE, Leong L, Somlo G, Twardowski P, Yen Y, Chow W, Tetef M, Lin P, Paz B, Koczywas M, Wagman L, Chu D, Frankel P, Stalter S, Doroshow JH. PMID: 17317834.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    7. A study of radiotherapy modalities combined with continuous 5-FU infusion for locally advanced gastrointestinal malignancies. Eur J Surg Oncol. 2004 Aug; 30(6):650-7. Shibata SI, Pezner R, Chu D, Doroshow JH, Chow WA, Leong LA, Margolin KA, McNamara MV, Morgan RJ, Raschko JW, Somlo G, Tetef ML, Yen Y, Synold TW, Wagman L, Vora N, Carroll M, Lin S, Longmate J. PMID: 15256240.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer. Cancer Chemother Pharmacol. 2004 Oct; 54(4):283-9. Morgan RJ, Synold TW, Gandara D, Muggia F, Scudder S, Reed E, Margolin K, Raschko J, Leong L, Shibata S, Tetef M, Vasilev S, McGonigle K, Longmate J, Yen Y, Chow W, Somlo G, Carroll M, Doroshow JH. PMID: 15184995.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    9. Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies. Cancer Chemother Pharmacol. 2004 Sep; 54(3):241-8. Chow WA, Synold TW, Tetef ML, Longmate J, Frankel P, Lawrence J, Al-Khadimi Z, Leong L, Lim D, Margolin K, Morgan RJ, Raschko J, Shibata S, Somlo G, Twardowski P, Yen Y, Doroshow JH. PMID: 15173955.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    10. Phase I study of cisdiamminedichloroplatinum in combination with azidothymidine in the treatment of patients with advanced malignancies. Cancer Chemother Pharmacol. 2003 Jun; 51(6):459-64. Morgan RJ, Newman EM, Sowers L, Scanlon K, Harrison J, Akman S, Leong L, Margolin K, Niland J, Raschko J, Somlo G, Carroll M, Chow W, Tetef M, Hamasaki V, Yen Y, Doroshow JH. PMID: 12695856.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    11. High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome. Br J Cancer. 2001 Jun 15; 84(12):1591-8. Somlo G, Doroshow JH, Synold T, Longmate J, Reardon D, Chow W, Forman SJ, Leong LA, Margolin KA, Morgan RJ, Raschko JW, Shibata SI, Tetef ML, Yen Y, Kogut N, Schriber J, Alvarnas J. PMID: 11401310; PMCID: PMC2363687.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    12. Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies. Clin Cancer Res. 2001 Jun; 7(6):1569-76. Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Raschko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH. PMID: 11410492.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    13. Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy. Cancer Chemother Pharmacol. 2001 Apr; 47(4):327-32. Morgan RJ, Synold T, Carr BI, Doroshow JH, Womack EP, Shibata S, Somlo G, Raschko J, Leong L, McNamara M, Chow W, Tetef M, Margolin K, Akman S, Longmate J. PMID: 11345649.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    14. Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies. Biol Blood Marrow Transplant. 2001; 7(5):284-93. Somlo G, Chow W, Hamasaki V, Leong L, Margolin K, Morgan R, Sniecinski I, Frankel P, Reardon D, Longmate E, Raschko J, Shibata S, O'Donnell M, Smith E, Tetef M, Forman S, Yen Y, Molina A, Doroshow H. PMID: 11400951.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    15. Keratin immunohistochemistry detects clinically significant metastases in bone marrow biopsy specimens in women with lobular breast carcinoma. Am J Surg Pathol. 2000 Dec; 24(12):1593-9. Lyda MH, Tetef M, Carter NH, Ikle D, Weiss LM, Arber DA. PMID: 11117779.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    16. Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis. Cancer Chemother Pharmacol. 2000; 46(1):19-26. Tetef ML, Margolin KA, Doroshow JH, Akman S, Leong LA, Morgan RJ, Raschko JW, Slatkin N, Somlo G, Longmate JA, Carroll MI, Newman EM. PMID: 10912573.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    17. A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A. Cancer Chemother Pharmacol. 2000; 46(5):403-10. Raschko JW, Synold TW, Chow W, Coluzzi P, Hamasaki V, Leong LA, Margolin KA, Morgan RJ, Shibata SI, Somlo G, Tetef ML, Yen Y, ter Veer A, Doroshow JH. PMID: 11127945.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    18. Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy. Blood. 1999 May 01; 93(9):2798-806. Somlo G, Sniecinski I, ter Veer A, Longmate J, Knutson G, Vuk-Pavlovic S, Bhatia R, Chow W, Leong L, Morgan R, Margolin K, Raschko J, Shibata S, Tetef M, Yen Y, Forman S, Jones D, Ashby M, Fyfe G, Hellmann S, Doroshow JH. PMID: 10216073.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsCTClinical Trials
    19. Cisplatin and infusional cytosine arabinoside for the treatment of colorectal adenocarcinoma: a phase II trial. Cancer Invest. 1999; 17(2):114-7. Tetef M, Leong L, Ahn C, Akman S, Chow W, Margolin K, Morgan RJ, Raschko J, Shibata S, Somlo G, Doroshow JH. PMID: 10071595.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    20. Antineoplastic activity of continuous exposure to dexrazoxane: potential new role as a novel topoisomerase II inhibitor. Semin Oncol. 1998 Aug; 25(4 Suppl 10):93-9. Synold TW, Tetef ML, Doroshow JH. PMID: 9768830.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    21. Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis. Cancer Res. 1998 Jul 01; 58(13):2793-800. Morgan RJ, Newman EM, Doroshow JH, McGonigle K, Margolin K, Raschko J, Chow W, Somlo G, Leong L, Tetef M, Shibata S, Hamasaki V, Carroll M, Vasilev S, Akman S, Coluzzi P, Wagman L, Longmate J, Paz B, Yen Y, Klevecz R. PMID: 9661893.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    22. High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support. Clin Cancer Res. 1997 Dec; 3(12 Pt 1):2337-45. Morgan RJ, Doroshow JH, Venkataraman K, Chang K, Raschko J, Somlo G, Leong L, Tetef M, Shibata S, Hamasaki V, Margolin K, Forman S, Akman S, Coluzzi P, Ahn C, Weiss L, Gadgil U, Harrison J. PMID: 9815632.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    23. High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival. J Clin Oncol. 1997 Aug; 15(8):2882-93. Somlo G, Doroshow JH, Forman SJ, Odom-Maryon T, Lee J, Chow W, Hamasaki V, Leong L, Morgan R, Margolin K, Raschko J, Shibata S, Tetef M, Yen Y, Simpson J, Molina A. PMID: 9256132.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    24. Effect of CD34+ selection and various schedules of stem cell reinfusion and granulocyte colony-stimulating factor priming on hematopoietic recovery after high-dose chemotherapy for breast cancer. Blood. 1997 Mar 01; 89(5):1521-8. Somlo G, Sniecinski I, Odom-Maryon T, Nowicki B, Chow W, Hamasaki V, Leong L, Margolin K, Morgan R, Raschko J, Shibata S, Tetef M, Molina A, Berenson RJ, Forman SJ, Doroshow JH. PMID: 9057632.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    25. Pharmacokinetics and toxicity of 120-hour continuous-infusion hydroxyurea in patients with advanced solid tumors. Cancer Chemother Pharmacol. 1997; 39(3):254-8. Newman EM, Carroll M, Akman SA, Chow W, Coluzzi P, Hamasaki V, Leong LA, Margolin KA, Morgan RJ, Raschko JW, Shibata S, Somlo G, Tetef M, Yen Y, Ahn CW, Doroshow JH. PMID: 8996529.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    26. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support. J Clin Oncol. 1996 Oct; 14(10):2631-7. Margolin K, Doroshow JH, Ahn C, Hamasaki V, Leong L, Morgan R, Raschko J, Shibata S, Somlo G, Tetef M. PMID: 8874321.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    27. 5-Fluorouracil and high-dose calcium leucovorin for hepatocellular carcinoma: a phase II trial. Cancer Invest. 1995; 13(5):460-3. Tetef M, Doroshow J, Akman S, Coluzzi P, Leong L, Margolin K, Morgan RJ, Raschko J, Shibata S, Somlo G, et al. PMID: 7552810.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    28. Mitomycin C and menadione for the treatment of advanced gastrointestinal cancers: a phase II trial. J Cancer Res Clin Oncol. 1995; 121(2):103-6. Tetef M, Margolin K, Ahn C, Akman S, Chow W, Coluzzi P, Leong L, Morgan RJ, Raschko J, Shibata S, et al. PMID: 7883772.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    29. Mitomycin C and menadione for the treatment of lung cancer: a phase II trial. Invest New Drugs. 1995; 13(2):157-62. Tetef M, Margolin K, Ahn C, Akman S, Chow W, Leong L, Morgan RJ, Raschko J, Somlo G, Doroshow JH. PMID: 8617579.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    Merry's Networks
    Concepts (147)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (11)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California